enfortumab vedotin,pembrolizumab
astellas,merck,Seagen
['bladder', 'urothelial', 'astellas', 'seagen', 'merck']
along with and merck we re proud to announce clinical trial results in first-line locally advanced/metastatic urothelial cancer that will be presented as late-breaking data at #esmo22. learn about the significance of these findings for the #bladdercancer community:
A pharma company dedicated to changing tomorrow by improving the health of people around the world. Tweets for U.S. audience. Guidelines: https://t.co/AJlgiDgp38